North Dakota State Investment Board Buys New Stake in Ventas, Inc. $VTR

North Dakota State Investment Board bought a new stake in Ventas, Inc. (NYSE:VTR) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 15,534 shares of the real estate investment trust’s stock, valued at approximately $1,202,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of VTR. Vanguard Group Inc. grew its stake in Ventas by 3.2% in the 4th quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust’s stock valued at $5,876,856,000 after buying an additional 2,349,176 shares during the last quarter. UBS Group AG grew its stake in Ventas by 142.4% in the 3rd quarter. UBS Group AG now owns 3,507,841 shares of the real estate investment trust’s stock valued at $245,514,000 after buying an additional 2,060,770 shares during the last quarter. Lasalle Investment Management Securities LLC grew its stake in Ventas by 1,135.1% in the 3rd quarter. Lasalle Investment Management Securities LLC now owns 1,552,880 shares of the real estate investment trust’s stock valued at $108,686,000 after buying an additional 1,427,151 shares during the last quarter. Invesco Ltd. grew its stake in Ventas by 21.5% in the 3rd quarter. Invesco Ltd. now owns 5,847,604 shares of the real estate investment trust’s stock valued at $409,274,000 after buying an additional 1,034,634 shares during the last quarter. Finally, State Street Corp grew its stake in Ventas by 3.3% in the 3rd quarter. State Street Corp now owns 28,927,015 shares of the real estate investment trust’s stock valued at $2,038,176,000 after buying an additional 928,386 shares during the last quarter. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Ventas Price Performance

Shares of Ventas stock opened at $88.38 on Wednesday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. The firm’s 50-day simple moving average is $85.18 and its 200-day simple moving average is $81.58. Ventas, Inc. has a twelve month low of $61.76 and a twelve month high of $91.06. The firm has a market cap of $42.97 billion, a P/E ratio of 160.68, a price-to-earnings-growth ratio of 2.16 and a beta of 0.74.

Ventas (NYSE:VTR) last issued its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a net margin of 4.25% and a return on equity of 2.09%. The business had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter last year, the firm posted $0.84 earnings per share. Ventas’s revenue was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, research analysts expect that Ventas, Inc. will post 3.86 EPS for the current fiscal year.

Ventas Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Tuesday, June 30th. Ventas’s payout ratio is 378.18%.

Insider Buying and Selling at Ventas

In other news, Director Walter C. Rakowich sold 1,152 shares of Ventas stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the sale, the director directly owned 28,349 shares in the company, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.53% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. UBS Group raised their target price on shares of Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a research note on Monday, May 4th. JPMorgan Chase & Co. increased their price target on shares of Ventas from $93.00 to $94.00 and gave the company an “overweight” rating in a report on Monday, May 11th. BMO Capital Markets reissued an “outperform” rating and issued a $100.00 price target on shares of Ventas in a report on Monday, May 4th. Jefferies Financial Group upped their price target on Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, May 12th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $93.00 price target on shares of Ventas in a report on Monday, February 9th. Fourteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $94.63.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.